420 related articles for article (PubMed ID: 16950655)
1. Complete regression of established subcutaneous B16 murine melanoma tumors after delivery of an HIV-1 Vpr-expressing plasmid by in vivo electroporation.
McCray AN; Ugen KE; Muthumani K; Kim JJ; Weiner DB; Heller R
Mol Ther; 2006 Nov; 14(5):647-55. PubMed ID: 16950655
[TBL] [Abstract][Full Text] [Related]
2. Enhancement of anti-melanoma activity of a plasmid expressing HIV-1 Vpr delivered through in vivo electroporation.
McCray AN; Ugen KE; Heller R
Cancer Biol Ther; 2007 Aug; 6(8):1269-75. PubMed ID: 17700061
[TBL] [Abstract][Full Text] [Related]
3. Anti-cancer activity of the HIV accessory molecule viral protein R (Vpr): Delivery as a DNA expression plasmid or biologically active peptides.
Muthumani K; Lambert VM; Kawalekar O; Heller R; Kim JJ; Weiner DB; Ugen KE
Vaccine; 2010 Feb; 28(8):2005-10. PubMed ID: 20188256
[TBL] [Abstract][Full Text] [Related]
4. Targeted liposomal c-myc antisense oligodeoxynucleotides induce apoptosis and inhibit tumor growth and metastases in human melanoma models.
Pastorino F; Brignole C; Marimpietri D; Pagnan G; Morando A; Ribatti D; Semple SC; Gambini C; Allen TM; Ponzoni M
Clin Cancer Res; 2003 Oct; 9(12):4595-605. PubMed ID: 14555535
[TBL] [Abstract][Full Text] [Related]
5. Regression of subcutaneous B16 melanoma tumors after intratumoral delivery of an IL-15-expressing plasmid followed by in vivo electroporation.
Ugen KE; Kutzler MA; Marrero B; Westover J; Coppola D; Weiner DB; Heller R
Cancer Gene Ther; 2006 Oct; 13(10):969-74. PubMed ID: 16763607
[TBL] [Abstract][Full Text] [Related]
6. Electrically mediated delivery of vector plasmid DNA elicits an antitumor effect.
Heller LC; Coppola D
Gene Ther; 2002 Oct; 9(19):1321-5. PubMed ID: 12224015
[TBL] [Abstract][Full Text] [Related]
7. Anticancer effect of a lentiviral vector capable of expressing HIV-1 Vpr.
Pang S; Kang MK; Kung S; Yu D; Lee A; Poon B; Chen IS; Lindemann B; Park NH
Clin Cancer Res; 2001 Nov; 7(11):3567-73. PubMed ID: 11705878
[TBL] [Abstract][Full Text] [Related]
8. Effective gene transfer to solid tumors using different nonviral gene delivery techniques: electroporation, liposomes, and integrin-targeted vector.
Cemazar M; Sersa G; Wilson J; Tozer GM; Hart SL; Grosel A; Dachs GU
Cancer Gene Ther; 2002 Apr; 9(4):399-406. PubMed ID: 11960291
[TBL] [Abstract][Full Text] [Related]
9. Effective tumor therapy with plasmid-encoded cytokines combined with in vivo electroporation.
Lohr F; Lo DY; Zaharoff DA; Hu K; Zhang X; Li Y; Zhao Y; Dewhirst MW; Yuan F; Li CY
Cancer Res; 2001 Apr; 61(8):3281-4. PubMed ID: 11309280
[TBL] [Abstract][Full Text] [Related]
10. Plasmid DNA gene therapy: studies with the human interleukin-2 gene in tumor cells in vitro and in the murine B16 melanoma model in vivo.
Parker SE; Khatibi S; Margalith M; Anderson D; Yankauckas M; Gromkowski SH; Latimer T; Lew D; Marquet M; Manthorpe M; Hobart P; Hersh E; Stopeck AT; Norman J
Cancer Gene Ther; 1996; 3(3):175-85. PubMed ID: 8725882
[TBL] [Abstract][Full Text] [Related]
11. Suppression of tumor growth by intratumoral injection of short hairpin RNA-expressing plasmid DNA targeting beta-catenin or hypoxia-inducible factor 1alpha.
Takahashi Y; Nishikawa M; Takakura Y
J Control Release; 2006 Nov; 116(1):90-5. PubMed ID: 17056147
[TBL] [Abstract][Full Text] [Related]
12. Gene silencing in primary and metastatic tumors by small interfering RNA delivery in mice: quantitative analysis using melanoma cells expressing firefly and sea pansy luciferases.
Takahashi Y; Nishikawa M; Kobayashi N; Takakura Y
J Control Release; 2005 Jul; 105(3):332-43. PubMed ID: 15936841
[TBL] [Abstract][Full Text] [Related]
13. Regression of established subcutaneous B16-F10 murine melanoma tumors after gef gene therapy associated with the mitochondrial apoptotic pathway.
Prados J; Melguizo C; Ortiz R; Boulaiz H; Carrillo E; Segura A; Rodríguez-Herva JJ; Ramos JL; Aránega A
Exp Dermatol; 2010 Apr; 19(4):363-71. PubMed ID: 19645856
[TBL] [Abstract][Full Text] [Related]
14. Phenothiazines induce apoptosis in a B16 mouse melanoma cell line and attenuate in vivo melanoma tumor growth.
Gil-Ad I; Shtaif B; Levkovitz Y; Nordenberg J; Taler M; Korov I; Weizman A
Oncol Rep; 2006 Jan; 15(1):107-12. PubMed ID: 16328041
[TBL] [Abstract][Full Text] [Related]
15. Electrotransfer of gene encoding endostatin into normal and neoplastic mouse tissues: inhibition of primary tumor growth and metastatic spread.
Cichoń T; Jamrozy L; Glogowska J; Missol-Kolka E; Szala S
Cancer Gene Ther; 2002 Sep; 9(9):771-7. PubMed ID: 12189527
[TBL] [Abstract][Full Text] [Related]
16. Antitumor effect of cytosine deaminase/5-fluorocytosine suicide gene therapy system mediated by Bifidobacterium infantis on melanoma.
Yi C; Huang Y; Guo ZY; Wang SR
Acta Pharmacol Sin; 2005 May; 26(5):629-34. PubMed ID: 15842785
[TBL] [Abstract][Full Text] [Related]
17. Combination electro-gene therapy using herpes virus thymidine kinase and interleukin-12 expression plasmids is highly efficient against murine carcinomas in vivo.
Goto T; Nishi T; Kobayashi O; Tamura T; Dev SB; Takeshima H; Kochi M; Kuratsu J; Sakata T; Ushio Y
Mol Ther; 2004 Nov; 10(5):929-37. PubMed ID: 15509510
[TBL] [Abstract][Full Text] [Related]
18. p53 alone or in combination with antisense cyclin D1 induces apoptosis and reduces tumor size in human melanoma.
Sauter ER; Takemoto R; Litwin S; Herlyn M
Cancer Gene Ther; 2002 Oct; 9(10):807-12. PubMed ID: 12224020
[TBL] [Abstract][Full Text] [Related]
19. Liposomal lipid and plasmid DNA delivery to B16/BL6 tumors after intraperitoneal administration of cationic liposome DNA aggregates.
Reimer DL; Kong S; Monck M; Wyles J; Tam P; Wasan EK; Bally MB
J Pharmacol Exp Ther; 1999 May; 289(2):807-15. PubMed ID: 10215656
[TBL] [Abstract][Full Text] [Related]
20. Induction of M-phase arrest and apoptosis after HIV-1 Vpr expression through uncoupling of nuclear and centrosomal cycle in HeLa cells.
Watanabe N; Yamaguchi T; Akimoto Y; Rattner JB; Hirano H; Nakauchi H
Exp Cell Res; 2000 Aug; 258(2):261-9. PubMed ID: 10896777
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
